 STOUGHTON, Mass., May 20, 2021 GLOBE NEWSWIRE -- Collegium Pharmaceutical, Inc. Nasdaq: COLL, a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conference: 